691 related articles for article (PubMed ID: 24092631)
21. Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease.
Chavassieux P; Seeman E; Delmas PD
Endocr Rev; 2007 Apr; 28(2):151-64. PubMed ID: 17200084
[TBL] [Abstract][Full Text] [Related]
22. Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human single trabeculae.
Busse B; Hahn M; Soltau M; Zustin J; Püschel K; Duda GN; Amling M
Bone; 2009 Dec; 45(6):1034-43. PubMed ID: 19679206
[TBL] [Abstract][Full Text] [Related]
23. Overview of osteoporosis: pathophysiology and determinants of bone strength.
Bono CM; Einhorn TA
Eur Spine J; 2003 Oct; 12 Suppl 2(Suppl 2):S90-6. PubMed ID: 13680312
[TBL] [Abstract][Full Text] [Related]
24. Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance.
Knott L; Bailey AJ
Bone; 1998 Mar; 22(3):181-7. PubMed ID: 9514209
[TBL] [Abstract][Full Text] [Related]
25. Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis.
Cohen A; Liu XS; Stein EM; McMahon DJ; Rogers HF; Lemaster J; Recker RR; Lappe JM; Guo XE; Shane E
J Clin Endocrinol Metab; 2009 Nov; 94(11):4351-60. PubMed ID: 19837923
[TBL] [Abstract][Full Text] [Related]
26. Site-specific changes in bone microarchitecture, mineralization, and stiffness during lactation and after weaning in mice.
Liu XS; Ardeshirpour L; VanHouten JN; Shane E; Wysolmerski JJ
J Bone Miner Res; 2012 Apr; 27(4):865-75. PubMed ID: 22189918
[TBL] [Abstract][Full Text] [Related]
27. Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.
Kühnisch J; Seto J; Lange C; Schrof S; Stumpp S; Kobus K; Grohmann J; Kossler N; Varga P; Osswald M; Emmerich D; Tinschert S; Thielemann F; Duda G; Seifert W; El Khassawna T; Stevenson DA; Elefteriou F; Kornak U; Raum K; Fratzl P; Mundlos S; Kolanczyk M
PLoS One; 2014; 9(1):e86115. PubMed ID: 24465906
[TBL] [Abstract][Full Text] [Related]
28. Bone geometry and skeletal fragility.
Bouxsein ML; Karasik D
Curr Osteoporos Rep; 2006 Jun; 4(2):49-56. PubMed ID: 16822403
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of osteoporosis therapy: a bone strength perspective.
Bouxsein ML
Clin Cornerstone; 2003; Suppl 2():S13-21. PubMed ID: 15035555
[TBL] [Abstract][Full Text] [Related]
30. American College of Sports Medicine position stand. Osteoporosis and exercise.
Med Sci Sports Exerc; 1995 Apr; 27(4):i-vii. PubMed ID: 7791573
[TBL] [Abstract][Full Text] [Related]
31. Diseases affecting bone quality: beyond osteoporosis.
Unnanuntana A; Rebolledo BJ; Khair MM; DiCarlo EF; Lane JM
Clin Orthop Relat Res; 2011 Aug; 469(8):2194-206. PubMed ID: 21107923
[TBL] [Abstract][Full Text] [Related]
32. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis.
Legrand E; Chappard D; Pascaretti C; Duquenne M; Krebs S; Rohmer V; Basle MF; Audran M
J Bone Miner Res; 2000 Jan; 15(1):13-9. PubMed ID: 10646109
[TBL] [Abstract][Full Text] [Related]
33. [The challenges of the bone micro-architecture].
Rachidi M; Breban S; Benhamou CL
J Soc Biol; 2008; 202(4):265-73. PubMed ID: 19094925
[TBL] [Abstract][Full Text] [Related]
34. Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects.
Tjhia CK; Odvina CV; Rao DS; Stover SM; Wang X; Fyhrie DP
Bone; 2011 Dec; 49(6):1279-89. PubMed ID: 21958843
[TBL] [Abstract][Full Text] [Related]
35. Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover.
Fratzl-Zelman N; Roschger P; Misof BM; Nawrot-Wawrzyniak K; Pötter-Lang S; Muschitz C; Resch H; Klaushofer K; Zwettler E
Calcif Tissue Int; 2011 May; 88(5):378-87. PubMed ID: 21318401
[TBL] [Abstract][Full Text] [Related]
36. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
Garnero P; Delmas PD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
[TBL] [Abstract][Full Text] [Related]
37. Bone quality and osteoporosis therapy.
Martin RM; Correa PH
Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):186-99. PubMed ID: 20485908
[TBL] [Abstract][Full Text] [Related]
38. Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study.
Cohen A; Stein EM; Recker RR; Lappe JM; Dempster DW; Zhou H; Cremers S; McMahon DJ; Nickolas TL; Müller R; Zwahlen A; Young P; Stubby J; Shane E
J Clin Endocrinol Metab; 2013 May; 98(5):1971-81. PubMed ID: 23543660
[TBL] [Abstract][Full Text] [Related]
39. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
Felsenberg D; Boonen S
Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
[TBL] [Abstract][Full Text] [Related]
40. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
